Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Multi-Regional Trials Prompt FDA Interest In Sponsors' Trial Infrastructure Decisions

This article was originally published in The Pink Sheet Daily

Executive Summary

The need to ensure data quality necessitates a better understanding of how the data was collected, CDER's Robert O'Neill tells DIA.

You may also be interested in...



When Using Foreign Clinical Data, Be Prepared To Prove U.S. Applicability

When using data from clinical trials conducted outside the U.S. for an NDA, drug makers must be able to demonstrate that the data are applicable to the U.S. population and U.S. medical practice, Murray Lumpkin, FDA's deputy commissioner for international programs, said

Foreign Clinical Trials: FDA Oversight To Include More Training, Data Collection

Changes to FDA's policy for monitoring foreign clinical trials appear imminent after the Department of Health and Human Services Inspector General recommended the agency increase its oversight of data gathered outside the U.S

When Using Foreign Clinical Data, Be Prepared To Prove U.S. Applicability

When using data from clinical trials conducted outside the U.S. for an NDA, drug makers must be able to demonstrate that the data are applicable to the U.S. population and U.S. medical practice, Murray Lumpkin, FDA's deputy commissioner for international programs, said

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS070750

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel